Angstrom Bio, Inc.
PrivateLast Round
Early Funding
Jun 16, 2021
Total Funding Raised
$3M
Momentum Score
50 /100
Company Overview
Angstrom Bio, Inc. is a diagnostics company that develops a platform for sequencing-based molecular diagnostics using nanopore sequencing and machine learning.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Services & Consulting, Government Contracts, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Angstrom Bio, Inc. Comps
Public and private peers based on sector, stage, and business model.
Angstrom Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Early Funding | Jun 16, 2021 |
Key People
Founding team and executive leadership
Angstrom Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| GreyBird Ventures | Early Funding |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 17, 2026
Monthly visitors increased 63% MoM.
Angstrom Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Angstrom Bio, Inc.'s valuation, stock price, and market status.
